Home / Biotechnology / Global High Throughput Screening Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

Global High Throughput Screening Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

Published: Jun 2018 | Published By: Acute Market Research

High Throughput Screening Market: Growth, Future Prospects, and Competitive Analysis, 2018 - 2026 the global high throughput screening market was valued at US$ 13.2 Bn in 2017 and expected to reach US$ 24.4 Bn by 2026 at a CAGR of 7.1% during the forecast period from 2018 to 2026.

Market Insights

The global high throughput screening (HTS) market shows lucrative growth during the forecast period from 2018 to 2026, attributed to increasing demand for advanced HTS in pharmaceutical & biotech industry. The gradual shift from manual to automated systems along with integrated systems and high-end liquid handling software is growing significantly. HTS uses automated systems, sensitive detectors, and microfluidics to permit researchers rapidly perform millions of assays to determine the targeted drugs of large compound libraries of usually 100,000 compounds. Enhancement in robotic systems with superior workflow solutions for HTS will traction globally. HTS encompasses numerous steps such as reagent preparation, target identification, assay development, compound management, and library screening. HTS procedures also used to distinguish pharmacokinetic, metabolic, and toxicology detection data for new molecules and thus eventually reduces the overall cost of drug development.

New technology assessment in high throughput screening for discovery, increase in manufacturing and expansion of services to pharmaceutical firms, contract research organizations and universities are driving the market growth globally. Manufacturing of top HTS systems with high-end costs such as ultra high throughput screening (uHTS) and other standalone-automated systems will further spur revenue growth during the forecast period. The cell-based assay in the application segment is leading the global market owing to its high adeptness along with wide usage, mainly pharmaceuticals & biotechnology firms. Moreover, increasing R&D expenditure in developing nations along with government funding and advancements in HTS procedures will gain a significant share in the coming years. Major external factors include expansion of research facilities with top quality systems, acquisitions, and partnerships with small-scale HTS providers is generating significant revenue share globally. Additionally, novel cell culture approaches such as 3D cultures and miniaturization of the HTS platforms along with the utilization of bioinformatics, lab-on-a-chip, and label-free technology will drive market growth globally. Manufacturers are also focusing on providing data-rich software, custom engineering solutions with enhanced workflow solutions.

However, the high cost of advanced and automated HTS, less investment in R&D regulations for clinical usage & testing of drugs, less awareness and lack of skilled professionals in the developing nations are few factors limiting the growth of the high throughput screening market globally. Other factors comprise the scarce availability of robotic systems, complexity in data management software and economic slowdown are few limitations affecting the overall growth of the HTS market globally.

Key Market Movements:

• Globally, the high throughput screening market remains to exhibit a profitable growth with a CAGR of 7.1% for the period from 2018 to 2026
• Higher technology advancement in the automation process for HTS is gaining traction in the market
• Asia Pacific, Latin America, and Eastern Europe to show promising opportunities during the forecast period owing to increasing adoption of advanced automated systems with high-end workflow stations
• Growth of enhanced applications in the drug discovery platforms, accessibility of branded systems for primary & secondary screening, and increasing usage in biotechnology & pharmaceutical industries will contribute to the growth of the market
• Major players in this vertical are Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Agilent Technologies, Inc., Tecan Group Ltd., Aurora Biomed, Perkinelmer, Inc., Sigma Aldrich Corporation, Axxam Spa, Hamilton Company, Aurora Biomed, Inc., Danaher Corporation, Beckman Coulter Inc., GE Healthcare and others.

Chapter 1. Preface
1.1. Report Description
1.1.1. Study Purpose
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.3.4. Assumptions
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global High Throughput Screening Market Portraiture
2.2. Global High Throughput Screening Market, by Technology Type, 2017 (US$ Bn)
2.3. Global High Throughput Screening Market, by Application, 2017 (US$ Bn)
2.4. Global High Throughput Screening Market, by End User, 2017 (US$ Bn)
2.5. Global High Throughput Screening Market, by Geography, 2017US$ Bn)

Chapter 3. Global High Throughput Screening Market: Market Dynamics and Future Outlook
3.1. Market Overview
3.2. High Throughput Screening Market Technologies: Future Trends
3.3. Drivers
3.3.1. Driver 1
3.3.2. Driver 2
3.4. Challenges
3.4.1. Challenge 1
3.4.2. Challenge 2
3.5. Opportunities
3.5.1. Opportunity 1
3.5.2. Opportunity 2
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Competitive Landscape
3.7.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Global High Throughput Screening Market, by Technology Type, 2016 – 2026 (US$ Bn)
4.1. Overview
4.2. Cell Based Assays
4.3. Ultra High Throughput Screening
4.4. Lab-on-a-Chip
4.5. Bioinformatics
4.6. Label Free Technology

Chapter 5. Global High Throughput Screening Market, by Application, 2016 – 2026 (US$)
5.1. Overview
5.2. Target Identification
5.3. Primary & Secondary Screening
5.4. Toxicology Assessment
5.5. Others

Chapter 6. Global High Throughput Screening Market, by End User, 2016 – 2026 (US$)
6.1. Overview
6.2. Biotechnology & Pharmaceutical Industries
6.3. Academic & Government Research Institutes
6.4. Contract Research Organizations
6.5. Others

Chapter 7. Global High Throughput Screening Market, by Geography, 2016 – 2026 (US$ Bn)
7.1. Overview
7.2. North America High Throughput Screening Market Analysis, 2016 – 2026
7.2.1. North America High Throughput Screening Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.2.2. North America High Throughput Screening Market, by Application, 2016 – 2026 (US$ Bn)
7.2.3. North America High Throughput Screening Market, by End User, 2016 – 2026 (US$ Bn)
7.2.4. North America High Throughput Screening Market, by Country, 2016 – 2026 (US$ Bn)
7.2.4.1. U.S.
7.2.4.2. Canada
7.3. Europe High Throughput Screening Market Analysis, 2016 – 2026
7.3.1. Europe High Throughput Screening Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.3.2. Europe High Throughput Screening Market, by Application, 2016 – 2026 (US$ Bn)
7.3.3. Europe High Throughput Screening Market, by End User, 2016 – 2026 (US$ Bn)
7.3.4. Europe High Throughput Screening Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.3.4.1. U.K.
7.3.4.2. Germany
7.3.4.3. Rest of Europe
7.4. Asia Pacific High Throughput Screening Market Analysis, 2016 – 2026
7.4.1. Asia Pacific High Throughput Screening Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.4.2. Asia Pacific High Throughput Screening Market, by Application, 2016 – 2026 (US$ Bn)
7.4.3. Asia Pacific High Throughput Screening Market, by End User, 2016 – 2026 (US$ Bn)
7.4.4. Asia Pacific High Throughput Screening Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.4.4.1. Japan
7.4.4.2. China
7.4.4.3. Rest of APAC
7.5. Latin America High Throughput Screening Market Analysis, 2016 – 2026
7.5.1. Latin America High Throughput Screening Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.5.2. Latin America High Throughput Screening Market, by Application, 2016 – 2026 (US$ Bn)
7.5.3. Latin America High Throughput Screening Market, by End User, 2016 – 2026 (US$ Bn)
7.5.4. Latin America High Throughput Screening Market, by Country/Region, 2016 – 2026 (US$ Bn)
7.5.4.1. Brazil
7.5.4.2. Mexico
7.5.4.3. Rest of Latin America
7.6. Middle East & Africa (MEA) High Throughput Screening Market Analysis, 2016 – 2026
7.6.1. MEA High Throughput Screening Market, by Technology Type, 2016 – 2026 (US$ Bn)
7.6.2. MEA High Throughput Screening Market, by Application, 2016 – 2026 (US$ Bn)
7.6.3. MEA High Throughput Screening Market, by End User, 2016 – 2026 (US$ Bn)
7.6.4. MEA High Throughput Screening Market, by Region, 2016 – 2026 (US$ Bn)
7.6.4.1. GCC
7.6.4.2. Rest of MEA

Chapter 8. Company Profiles
8.1. Thermo Fisher Scientific, Inc.
8.1.1. Business Description
8.1.2. Financial Information (Subject to data availability)
8.1.3. Product Portfolio
8.1.4. Key Developments
8.2. Bio-Rad Laboratories
8.3. Agilent Technologies, Inc.
8.4. Tecan Group Ltd.
8.5. Aurora Biomed
8.6. Perkinelmer, Inc.
8.7. Sigma Aldrich Corporation
8.8. Axxam Spa
8.9. Hamilton Company
8.10. Aurora Biomed, Inc.
8.11. Danaher Corporation
8.12. GE Healthcare

TABLE 1 Market Snapshot: Global High Throughput Screening Market
TABLE 2 Global High Throughput Screening Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 3 Global High Throughput Screening Market, by Application, 2016–2026 (US$ Bn)
TABLE 4 Global High Throughput Screening Market, by End User, 2016–2026 (US$ Bn)
TABLE 5 Global High Throughput Screening Market, by Geography, 2016–2026 (US$ Bn)
TABLE 6 North America High Throughput Screening Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 7 North America High Throughput Screening Market, by Application, 2016–2026 (US$ Bn)
TABLE 8 North America High Throughput Screening Market, by End User, 2016–2026 (US$ Bn)
TABLE 9 North America High Throughput Screening Market, by Country, 2016–2026 (US$ Bn)
TABLE 10 Europe High Throughput Screening Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 11 Europe High Throughput Screening Market, by Application, 2016–2026 (US$ Bn)
TABLE 12 Europe High Throughput Screening Market, by End User, 2016–2026 (US$ Bn)
TABLE 13 Europe High Throughput Screening Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 14 Latin America High Throughput Screening Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 15 Latin America High Throughput Screening Market, by Application, 2016–2026 (US$ Bn)
TABLE 16 Latin America High Throughput Screening Market, by End User, 2016–2026 (US$ Bn)
TABLE 17 Latin America High Throughput Screening Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 18 Asia Pacific High Throughput Screening Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 19 Asia Pacific High Throughput Screening Market, by Application, 2016–2026 (US$ Bn)
TABLE 20 Asia Pacific High Throughput Screening Market, by End User, 2016–2026 (US$ Bn)
TABLE 21 Asia Pacific High Throughput Screening Market, by Country/Region, 2016–2026 (US$ Bn)
TABLE 22 Middle East & Africa High Throughput Screening Market, by Technology Type, 2016–2026 (US$ Bn)
TABLE 23 Middle East & Africa High Throughput Screening Market, by Application, 2016–2026 (US$ Bn)
TABLE 24 Middle East & Africa High Throughput Screening Market, by End User, 2016–2026 (US$ Bn)
TABLE 25 Middle East & Africa High Throughput Screening Market, by Region, 2016–2026 (US$ Bn)
TABLE 26 Thermo Fisher Scientific: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 27 Bio-Rad Laboratories: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 28 Agilent Technologies, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 29 Tecan Group Ltd.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 30 Aurora Biomed: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 31 PerkinElmer, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 32 GE Healthcare: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 33 Sigma Aldrich Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 34 Axxam Spa: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 35 Hamilton Company: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments
TABLE 36 Aurora Biomed, Inc.: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments)
TABLE 37 Danaher Corporation: Company Snapshot (Company Overview; Product Portfolio; Financial Information; Key Developments

FIG. 1 Global High Throughput Screening Market: Research Methodology
FIG. 2 Market Size Estimation – Top Down & Bottom up Approach
FIG. 3 Global High Throughput Screening Market Segmentation
FIG. 4 Global High Throughput Screening Market, by Technology Type, 2017 (US$ Bn)
FIG. 5 Global High Throughput Screening Market, by Application, 2017 (US$ Bn)
FIG. 6 Global High Throughput Screening Market, by End User, 2017 (US$ Bn)
FIG. 7 Global High Throughput Screening Market, by Geography, 2017 (US$ Bn)
FIG. 8 Attractive Investment Proposition, by Geography, 2017
FIG. 9 Global Market Positioning of Key High Throughput Screening Solutions Manufacturers, 2017
FIG. 10 Global Cell Based Assays for HTS Market, 2016–2026 (US$ Bn)
FIG. 11 Global Ultra High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 12 Global Lab-on-a-Chip for HTS Market, 2016–2026 (US$ Bn)
FIG. 13 Global Bioinformatics for HTS Market, 2016–2026 (US$ Bn)
FIG. 14 Global Label Free Technology for HTS Market, 2016–2026 (US$ Bn)
FIG. 15 Global Drug Discovery Platforms Application for HTS Market, 2016–2026 (US$ Bn)
FIG. 16 Global Primary & Secondary Screening Application for HTS Market, 2016–2026 (US$ Bn)
FIG. 17 Global Toxicology Assessment Application for HTS Market, 2016–2026 (US$ Bn)
FIG. 18 Global Other Applications for HTS Market, 2016–2026 (US$ Bn)
FIG. 19 Global HTS Market in Biotech & Pharma Industries, 2016–2026 (US$ Bn)
FIG. 20 Global HTS Market in Academic & Government Research Institutes, 2016–2026 (US$ Bn)
FIG. 21 Global HTS Market in Contract Research Organizations, 2016–2026 (US$ Bn)
FIG. 22 Global HTS Market in Other End-Users, 2016–2026 (US$ Bn)
FIG. 23 U.S. High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 24 Canada High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 25 U.K. High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 26 Germany High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 27 Rest of Europe High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 28 Japan High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 29 China High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 30 Rest of Asia Pacific High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 31 Brazil High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 32 Mexico High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 33 Rest of Latin America High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 34 GCC High Throughput Screening Market, 2016–2026 (US$ Bn)
FIG. 35 Rest of Middle East & Africa High Throughput Screening Market, 2016–2026 (US$ Bn)

Choose License Type
 
Contact Information
24/7 Research Support
Phone: +1-855-455-8662
sales@acutemarketreports.com
Get in Touch with us
join us on Facebook
Follow us on Twitter
Follow us on LinkedIn
Add us on Google +